Prevalence and prognostic relevance of electrocardiographic abnormalities among patients with ANCA-associated vasculitis
Authors:
- Louis NygaardLNLouis Nygaard
- Caroline Hundborg LiboriussenCLCaroline Hundborg Liboriussen
- Nicholas CarlsonNCNicholas Carlson
- Karl Emil Nelveg-KristensenKNKarl Emil Nelveg-Kristensen
- Salome KristensenSKSalome Kristensen
- Mikkel Porsborg AndersenMAMikkel Porsborg Andersen
- Helle Collatz ChristensenHCHelle Collatz Christensen
- Kristian KragholmKKKristian Kragholm
- Claus GraffCGClaus Graff
- Christian Torp-PedersenCTChristian Torp-Pedersen
- Per IvarsenPIPer Ivarsen
- 12 August 2024
- journal article
- research article
- Published by Oxford University Press (OUP) in Rheumatology
Abstract
Objectives: Current guidelines provide limited evidence for cardiovascular screening in ANCA-associated vasculitis (AAV). This study aimed to investigate the prevalence of ECG abnormalities and associations between no, minor or major ECG abnormalities with cardiovascular mortality in AAV patients compared with matched controls. Methods: Using a risk-set matched cohort design, patients diagnosed with granulomatosis with polyangiitis or microscopic polyangiitis with digital ECGs were identified from Danish registers from 2000 to 2021. Patients were matched 1:3 to controls without AAV on age, sex and year of ECG measurement. Associated hazards of cardiovascular mortality according to ECG abnormalities were assessed in Cox regression models adjusted for age, sex and comorbidities, with subsequent computation of 5-year risk of cardiovascular mortality standardized to the age- and sex-distribution of the sample. Results: A total of 1431 AAV patients were included (median age: 69 years, 52.3% male). Median follow-up was 4.8 years. AAV was associated with a higher prevalence of left ventricular hypertrophy (17.5% vs 12.5%), ST-T deviations (10.1% vs 7.1%), atrial fibrillation (9.6% vs 7.5%) and QTc prolongation (5.9% vs 3.6%). Only AAV patients with major ECG abnormalities demonstrated a significantly elevated risk of cardiovascular mortality [HR 1.99 (1.49–2.65)] compared with controls. This corresponded to a 5-year risk of cardiovascular mortality of 19.14% (16–22%) vs 9.41% (8–11%). Conclusion: Patients with AAV demonstrated a higher prevalence of major ECG abnormalities than controls. Notably, major ECG abnormalities were associated with a significantly increased risk of cardiovascular mortality. These results advocate for the inclusion of ECG assessment into routine clinical care for AAV patients.Keywords
This publication has 43 references indexed in Scilit:
- The Danish Nationwide Electrocardiogram (ECG) CohortEuropean Journal of Epidemiology, 2024
- Comorbidities and health-related quality of life in Patients with Antineutrophil Cytoplasmic Antibody (ANCA) - associated vasculitisAutoimmunity Reviews, 2021
- Relation of Minor Electrocardiographic Abnormalities to Cardiovascular MortalityThe American Journal of Cardiology, 2019
- Screening for Cardiovascular Disease Risk With ElectrocardiographyJAMA, 2018
- Prevalence and prognostic relevance of cardiac involvement in ANCA-associated vasculitis: Eosinophilic granulomatosis with polyangiitis and granulomatosis with polyangiitisInternational Journal of Cardiology, 2015
- The Danish Civil Registration System as a tool in epidemiologyEuropean Journal of Epidemiology, 2014
- J-Shaped Association Between QTc Interval Duration and the Risk of Atrial FibrillationJACC, 2013
- Association of Major and Minor ECG Abnormalities With Coronary Heart Disease EventsJAMA, 2012
- Increased morbidity from ischemic heart disease in patients with Wegener's granulomatosisArthritis & Rheumatism, 2009
- AHA/ACCF/HRS Recommendations for the Standardization and Interpretation of the ElectrocardiogramJACC, 2009